Prodynorphin, proenkephalin and κ opioid receptor mRNA responses to acute “binge” cocaine

Branch, A.D., Unterwald, E.M., Lee, S.E. and Kreek, M.J., Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay, Mol. Brain Res., 14 (1992) 231–238. Chen, Y., Mestek, A., Liu, J. and Yu, L., Molecular cloning of a rat κ-opioid receptor reveals sequence similarities to the μ- and δ-opioid receptors, Biochem. J., 295 (1993) 625–628. Civelli, O., Douglass, J., Goldstein, A. and Herbert, E., Sequence and expression of the rat prodynorphin gene, Proc. Natl. Acad. Sci. USA, 82 (1985) 4291–4295. Claye, L.H., Maisonneuve, I.M., Yu, J., Ho, A. and Kreek, M.J., Local perfusion of dynorphin A1–17 reduces extracellular dopamine levels in the nucleus accumbens, NIDA Res. Monogr. Ser., (1996) in press. Daunais, J.B. and McGinty, J.F., Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs, Mol. Brain Res., 29 (1995) 201–210. Daunais, J.B., Roberts, D.C. and McGinty, J.F., Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum, NeuroReport, 4 (1993) 543–546. Di Chiara, G. and Imperato, A., Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats, J. Pharmacol. Exp. Ther., 244 (1988) 1067–1080. Hannon, G.J., Maroney, P.A., Branch, A., Benenfield, B.J., Robertson, H.D. and Nilsen, T.W., Accurate processing of human pre-rRNA in vitro, Mol. Cell. Biol., 9 (1989) 4422–4431. Heikkila, R.E., Orlansky, H. and Cohen, G., Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices, Biochem. Pharmacol., 24 (1975) 847–852. Hurd, Y.L., Brown, E.E., Finlay, J.M., Fibiger, H.C. and Gerfen, C.R., Cocaine self-administration differentially alters mRNA expression of striatal peptides, Mol. Brain Res., 13 (1992) 165–170. Hurd, Y.L. and Herkenham, M., Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides, Mol. Brain Res., 16 (1992) 97–104. Maisonneuve, I.M., Ho, A. and Kreek, M.J., Chronic administration of a cocaine “binge” alters basal extracellular dopamine levels in male rats: an in vivo microdialysis study, J. Pharmacol. Exp. Ther., 272 (1995) 652–657. Maisonneuve, I.M. and Kreek, M.J., Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: an in vivo microdialysis study, J. Pharmacol. Exp. Ther., 268 (1994) 916–921. Manzanares, J., Lookingland, K.J. and Moore, K.E., Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain, J. Pharmacol. Exp. Ther., 256 (1991) 500–505. Mulder, A.H., Wardeh, G., Hogenboom, F. and Frankhuyzen, A.L., κ- and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release, Nature, 308 (1984) 278–280. Pickel, V.M., Chan, J. and Sesack, S.R., Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra, Brain Res., 602 (1993) 275–289. Reith, M.E., Sershen, H. and Lajtha, A., Saturable [3H]cocaine binding in central nervous system of mouse, Life Sci., 27 (1980) 1055–1062. Sivam, S.P., Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism, J. Pharmacol. Exp. Ther., 250 (1989) 818–824. Smiley, P.L., Johnson, M., Bush, L., Gibb, J.W. and Hanson, G.R., Effects of cocaine on extrapyramidal and limbic dynorphin systems, J. Pharmacol. Exp. Ther., 253 (1990) 938–943. Spanagel, R., Herz, A. and Shippenberg, T.S., The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study, J. Neurochem., 55 (1990) 1734–1740. Spangler, R., Ho, A., Zhou, Y., Maggos, C., Yuferov, V. and Kreek, M.J., Regulation of kappa opioid receptor mRNA in the rat brain by “binge” pattern cocaine administration and correlation with preprodynorphin mRNA, Mol. Brain Res., 38 (1996) 71–76. Spangler, R., Unterwald, E.M. and Kreek, M.J., “Binge” cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen, Mol. Brain Res., 19 (1993) 323–327. Spangler, R., Zhou, Y., Maggos, C.E., Zlobin, A., Ho, A. and Kreek, M.J., Dopamine antagonist and “binge” cocaine effects on rat opioid and dopamine transporter mRNAs, NeuroReport, 7 (1996) 2196–2200. Spangler, R., Zhou, Y., Unterwald, E.M., Yuferov, V., Ho, A. and Kreek, M.J., Kappa opioid receptor mRNA levels in the rat brain: effects of dopamine antagonists and cocaine, Regul. Peptides, 54 (1994) 283–284. Steiner, H. and Gerfen, C.R., Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum, J. Neurosci., 13 (1993) 5066–5081. Unterwald, E.M., Rubenfeld, J.M. and Kreek, M.J., Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors, NeuroReport, 5 (1994) 1613–1616. Vincent, S., Hökfelt, T., Christensson, I. and Terenius, L., Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway, Eur. J. Pharmacol., 85 (1982) 251–252. Werling, L.L., Frattali, A., Portoghese, P.S., Takemori, A.E. and Cox, B.M., Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs, J. Pharmacol. Exp. Ther., 246 (1988) 282–286. Yoshikawa, K., Williams, C. and Sabol, S.L., Rat brain preproenkephalin mRNA: cDNA cloning, primary structure, and distribution in the central nervous system, J. Biol. Chem., 259 (1984) 14301–14308.